Diadema Partners LP Portfolio Holdings

Diadema Partners LP

  • $391 Billion
  • Q3 2025

Diadema Partners LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $391 Billion distributed in 130 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Regeneron Pharmaceuticals, Inc. with a value of $17B, Soleno Therapeutics Inc with a value of $12B, Biomarin Pharmaceutical Inc with a value of $11.5B, Vaxcyte, Inc. with a value of $7.86B, and Indivior PLC with a value of $6.13B.

Examining the 13F form we can see an increase of $62.8B in the current position value, from $328B to 391B.

Diadema Partners LP is based out at Morristown, NJ

Below you can find more details about Diadema Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $391 Billion
Healthcare: $313 Billion
ETFs: $13.3 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 130
  • Current Value $391 Billion
  • Prior Value $328 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 33 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 16 stocks
Track This Portfolio

Track Diadema Partners LP Portfolio

Follow Diadema Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diadema Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Diadema Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email